Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Single Cell Analysis Market
Estimated value of the worldwide single cell analysis market in 2023 was US$ XX billion, and by 2033, it is anticipated to reach US$ XX billion. The development of single-cell analysis technologies has been a major factor in the market's expansion. These technologies make it possible to investigate individual cells within a bulk population for the purposes of genomics, transcriptomics, proteomics, metabolomics, and cell-cell interactions. Technological developments in optical and electronic microscopy make it easier to analyze and work with individual cells in certain settings. Proteomic and metabolomic studies have also been transformed by the development of mass spectrometry techniques, which enable the quantification of thousands of proteins in hundreds of individual cells. The single-cell analysis market is growing as a result of these advancements, which open up new analytical opportunities.
Market Overview
Thanks to innovations like genome-wide transcriptome data gathering from single cells utilizing high-throughput sequencing (scRNA-seq), the single cell analysis market is expanding quickly. With this approach, problems that were previously thought to be unsolvable using traditional techniques like bulk RNA-seq or single-cell RT-qPCR can be resolved with unprecedented cellular resolution and genome-wide scope. Transcripts in a sample can be successfully and economically profiled using RNA-seq, which offers a snapshot of the transcriptome at the cellular level.
RNA molecules within each cell are quantified using scRNA-seq, providing information on gene expression at the level of a single cell. Numerous uses for this technique exist, such as the detection of tumor cells and the analysis of single-cell DNA mutations for the purpose of clinical decision-making and tumor cell monitoring. The scientific community has paid great attention to the biological relevance of cell-to-cell differences and the enormous potential of single-cell analysis in both fundamental research and clinical diagnostics, which has fueled the single cell analysis market's growth.
Key Insights
• By product, the consumables segments have dominated the market with a share largest terms of revenue.
• By application, the cancer segments have dominated the market share of about 32% and this will continue to grow well in the coming years.
• The library preparation and isolation segment will have a larger market share.
• By end user, the research and academic laboratories segment has contributed a market share.
• The North America region accounted largest revenue share and will gradually increase in the coming years.
Regional Stance
With the biggest market share, North America is clearly the dominant force in the single cell analysis market. The progress of single cell analysis technologies and applications is facilitated by a strong network of academic institutions, forward-thinking corporations, and regulatory frameworks that support this leadership position. The biomanufacturing industry's primary focus in North America presents numerous chances to utilize sustainable biomass resources around the country.
Renewable biomass can be combined with biomanufacturing skills to create a wide range of goods that can replace conventional petroleum-based production techniques. This change supports a number of businesses, including chemicals, medicines, fuels, and materials, and it also advances economic growth in line with sustainability goals. Beyond applications in human health, the field of biotechnology and biomanufacturing is expanding to include projects that address energy and climate change, improve food security, and support regional economic growth. Because of this, North America continues to lead the world in single cell analysis innovation and biomanufacturing, which fuels growth.
Report Highlights
By Product
Consumables category emerges as the main force in the single-cell analysis industry. The dominance of this category stems from its essential function of enabling the collection of single-cell data via multiple studies, each requiring different consumables, technology platforms, and capture timeframes. The term "consumables" refers to a variety of one-time use items that are necessary for the sterile and effective processing of cells and biological materials. These consist of consumables for cell separation and perfusion culture, materials for tiny reaction tanks, carrier culture kits, and single-use flask (SUF) kits. These consumables facilitate sorting, cell storage, and cryopreservation on a small- and large-scale, guaranteeing smooth operations in workflows for single-cell analysis.
Consumables are a major factor in the development of single-cell analysis technologies because they provide necessary instruments for cell processing and experimentation. Because it continues to meet the changing needs of researchers and biotechnologists who are driven to make groundbreaking discoveries in cellular biology, the consumables section of the market remains robust.
By Application
Market for single-cell analysis is dominated by the cancer application sector. This importance stems from the fact that intra-tumor heterogeneity occurs often in a variety of human cancer types. Molecularly unique clones with varying properties, including rates of proliferation, potential for metastasis, and reactions to treatment, frequently make up tumors. Comprehensive single-cell tumor analysis provides previously unattainable insights into the genesis, progression, and metastasis of malignancies. Significant genetic variety was found within tumors when single cells isolated from primary renal carcinomas were subjected to exome sequencing; only a small percentage of genetic lesions were identical across all tumor cells.
Differences in PIK3CA mutations between circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) and original and metastatic tumor tissues provide important insights into medication responses when analyzed in detail at the single-cell level. The single-cell analysis market is dominated by the cancer application segment because to the increased accuracy and efficacy of cancer treatments brought about by these insights into tumor heterogeneity and therapeutic efficacy at the single-cell level.
By Workflow
Within the single-cell analysis market, the segment that deals with isolation and library preparation has a bigger market share. This section covers all of the essential phases in the workflow for single-cell analysis, such as library preparation, computational analysis pipelines for scRNA-seq data, and single-cell isolation. The first stage in extracting transcriptome data from single cells is single-cell isolation. Different cell populations can be sorted using a variety of methods, including negative selection and fluorescent monoclonal antibody labeling. Sorting cells is made easier by fluorescent monoclonal antibodies that identify particular surface markers, and unstained populations can be isolated by applying magnetic separation or electrostatic deflection techniques.
Following isolation, a series of procedures are needed to generate scRNA-seq libraries, including cell lysis, reverse transcription into first-strand cDNA, second-strand synthesis, and cDNA amplification. To extract messenger RNAs (mRNAs), cells are usually lysed in a hypotonic solution and then subjected to poly(A)+ selection using poly(dT) primers. Prolonged technological progress in molecular and cell biology, along with enhancements in bioinformatics instruments, are well-positioned to augment fundamental science investigations and medical uses of sequencing technology. These developments simplify the process for single-cell analysis, encouraging the use of isolation and preparation methods for libraries and setting this market segment up for substantial growth.
By End User
In the single cell analysis market, the research and academic laboratories sector holds the biggest market share. In the past, only specialist laboratories possessing proficiency in manual techniques such as mouth pipetting and cell micromanipulation were allowed to conduct single cell analyses. But because to technological advances, single cell analysis is now a scalable procedure carried out on thousands or even millions of cells with fully automated equipment that is easily accessible at key facilities. Single-cell analysis has become more accessible thanks to automated equipment, allowing labs of different sizes to carry out complex studies and experiments.
The potential of single cell analysis is further enhanced by the emergence of new technologies that cover everything from single cell isolation to downstream procedures including imaging, functional tests, and library preparation. Workflows are streamlined and single cell research is advanced through the incorporation of laboratory automation, which also allows for faster data creation, higher throughput, and improved reproducibility. Research and university labs, thereby putting themselves at the forefront of ground-breaking discoveries in cellular biology and beyond, continue to fuel innovation and the growth of the single cell analysis market.
Market Dynamics
Driver
Emergence of next-generation sequencing (NGS) technologies
Discipline of single cell genome studies has emerged as a result of the development of next-generation sequencing (NGS) technologies and whole genome/transcriptome amplification (WGA/WTA) methodologies. This discipline makes use of multiparameter and high-throughput techniques for single-cell analysis, which makes it possible to explain heterogeneous differences between individual cells as well as cell-to-cell variability. To handle these complications, it is imperative that effective single cell analysis techniques be developed. The fact that single cell analysis techniques are widely used by biologists emphasizes how important they are to the advancement of science.
In fact, single-cell analysis has had a big impact on a lot of different scientific fields, like immunology, neuroscience, cancer biology, and more. The overall influence of single cell analysis across several scientific disciplines is driving the expansion of the single cell analysis market, even though the breadth of these discoveries is too great to fully describe.
Restraints
Data Preprocessing Challenges
Data preprocessing, aimed at converting raw measurements to bias-corrected and biologically meaningful signals, serves as a primary tool for single-cell analysis. However, gene expression profiling via single-cell RNA sequencing (scRNA-seq) encounters inherent noise compared to bulk RNA-seq, owing to extensive amplification of minute starting material and sparse sampling, resulting in significant distortions. A typical single-cell gene expression matrix often contains numerous zero entries, reflecting the inefficiency of RNA capture and conversion rate, coupled with DNA amplification bias. These factors contribute to distortions in gene expression profiles, leading to false-negative errors for highly expressed transcripts and inflated estimates of cell-to-cell variability for low-expressed transcripts.
market.
Opportunities
Rapid Technological Advancements
Single cell analysis market is highly promising due to the swift advancement of technology and techniques that enable comprehensive examination of a single cell's transcriptome and genome. The unique ancestry and purpose of every type of cell have been revealed by recent research, providing insight into how different cell types interact with one another and react to their surroundings. Understanding how cell networks coordinate responses at the population level can be achieved using experimental methods that make use of single-cell analysis. These methods also offer important new insights for future research areas. Thanks to developments in whole-genome and whole-transcriptome amplification, it is now possible to sequence and profile individual cell quantities of DNA and RNA to reveal genomic and transcriptomic heterogeneity in both healthy development and illness.
Each cell has a distinct genomic structure that makes it possible to renovate cell lineage trees more quickly and accurately. This helps with preimplantation analysis, genetic diagnosis in cancer research, and the identification of uncommon tumor cells. Additionally, single-cell methods are promising for deciphering the complex cellular interactions that underpin immune responses, especially when dealing with uncommon antigen-specific T- or B-cells.
Recent Developments
• In October 2023, Sony announced the launch of the FP7000 Spectral Cell Sorter, supporting high-parameter sorting with more than 44 colors. [
• In February 2024, ARRALYZE introduced CellShepherd, a fully autonomous single-cell platform for real-time monitoring of functional assays.
• In July 2022, Mission Bio launched an Early Access Program for single-cell measurable residual disease detection in blood cancers.
• In October 2023, Bruker completed the acquisition of PhenomeX.
• In April 2024, NanoString Technologies announced its acquisition by Bruker Corporation.
• In August 2023, Cell Microsystems acquired Fluxion Biosciences to broaden its cell analysis product and services portfolio.
• In January 2023, Agilent and Akoya Biosciences announced a partnership to drive multiplex tissue assay development for biopharma applications.
Key Players in the Single Cell Analysis Market
Thermo Fisher Scientific
Novogene corporation
Illumina Inc
BGI
Fluidigm corporation
Market Segmentation
By Product
Consumables
Instruments
By Application
Cancer
Neurology
Stem cell
Immunology next line in vitro fertilization
Noninvasive prenatal diagnosis
By Workflow
Downstream analysis
Single cell isolation and library preparation
Data analysis
By End User
Research and Academic Laboratories
Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostic Laboratories
Others
By Geography
North America
U.S.
Canada
Europe
Germany
France
United Kingdom
Rest of Europe
Asia Pacific
China
Japan
India
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Rest of Latin Americax
Middle East & Africa (MEA)
GCC
North Africa
South Africa
Rest of Middle East & Africa
Provide your email to get email notification when we publish new reports.